AzTrials
AzTrials

Quantitative Validation of Imaging SystemNCT01573390

Non Invasive and Non-Contact Imaging Of Tissue Oxygenation and Vascular Reactivity

An observational study of Quantitative Validation of Imaging System, run by Chandan K Sen at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

1. Quantitative validation of non-contact oxygenation imaging by the CWC imaging system 2. Quantitative validation of non-contact vascular function imaging by the CWC imaging system 3. Evaluation of the clinical usability of the CWC imaging system for further technology development and engineering improvement Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
0 participants
Where
1 siteUnited States
Study dates
Start not givento not given
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Interested healthy volunteers

Who may be able to join

  • Adult 18 years and older
  • No history of diabetes.
  • No history of vascular disease

Who cannot join

  • Under 18 years of age
  • Unable to provide informed consent
  • Prisoners
  • Current smoker

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University.

    Columbus, Ohio, 43210

Other trials in United States

About this study

Official title: Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.

  1. Quantitative validation of non-contact oxygenation imaging by the CWC imaging system
  2. Quantitative validation of non-contact vascular function imaging by the CWC imaging system
  3. Evaluation of the clinical usability of the CWC imaging system for further technology development and engineering improvement
Read the detailed description

The hyperspectral imaging technique estimates cutaneous tissue oxygenation by illuminating tissue and detecting tissue reflectance at different wavelengths. One major advantage of hyperspectral imaging is non-invasive and non-contact detection of tissue functional properties. The dual-mode imaging system integrates hyperspectral and thermal imaging modalities for simultaneous assessment of cutaneous tissue oxygenation and vascular function. This clinical protocol is defined to validate the CWC system on healthy human subjects

Keywords
Non-invasive, tissue-oxygenation, hyperspectral, CWC imaging system

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01573390
Study groupRoleWhat they receive
1Healthy participants.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Non-Contact Oxygenation Imagiing

    Quantitative validation of non-contact oxygenation imaging by the CWC imaging system

    Measured: 1 year

  2. Non-Contact Vascular Function Imaging

    Quantitative validation of non-contact vascular function imaging by the CWC imaging system

    Measured: 1 year

Secondary outcomes (1)
  1. Clinical usability for Comprehensive Wound Centers

    Evaluation of the clinical usability of the CWC imaging system for further technology development and engineering improvement.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2012 (estimated)

Why it stopped: most of the study team left the institution prior to study initiation

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01573390
Sponsor's protocol ID
2010H0017
Status last verified
Apr 2022
First submitted
5 Apr 2012
Last updated
28 Apr 2022
Results posted
No
Data monitoring committee
No

Publications

  • Xu RX, Huang K, Qin R, Huang J, Xu JS, Ding L, Gnyawali US, Gordillo GM, Gnyawali SC, Sen CK. Dual-mode imaging of cutaneous tissue oxygenation and vascular function. J Vis Exp. 2010 Dec 8;(46):2095. doi: 10.3791/2095.

    PubMed 21178967
  • Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999 Sep 2;341(10):738-46. doi: 10.1056/NEJM199909023411006. No abstract available.

    PubMed 10471461
  • Reiber GE. Diabetic foot care. Financial implications and practice guidelines. Diabetes Care. 1992 Mar;15 Suppl 1:29-31. doi: 10.2337/diacare.15.1.s29.

    PubMed 1559416
  • Broughton G 2nd, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):1e-S-32e-S. doi: 10.1097/01.prs.0000222562.60260.f9.

    PubMed 16801750
  • Sen CK. Wound healing essentials: let there be oxygen. Wound Repair Regen. 2009 Jan-Feb;17(1):1-18. doi: 10.1111/j.1524-475X.2008.00436.x.

    PubMed 19152646
  • Leach RM, Treacher DF. Oxygen transport-2. Tissue hypoxia. BMJ. 1998 Nov 14;317(7169):1370-3. doi: 10.1136/bmj.317.7169.1370. No abstract available.

    PubMed 9812940
  • Treacher DF, Leach RM. Oxygen transport-1. Basic principles. BMJ. 1998 Nov 7;317(7168):1302-6. doi: 10.1136/bmj.317.7168.1302. No abstract available.

    PubMed 9804723
  • Chang N, Goodson WH 3rd, Gottrup F, Hunt TK. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann Surg. 1983 Apr;197(4):470-8. doi: 10.1097/00000658-198304000-00017.

    PubMed 6830354
  • Wilson DF. Oxygen dependent quenching of phosphorescence: a perspective. Adv Exp Med Biol. 1992;317:195-201. doi: 10.1007/978-1-4615-3428-0_20.

    PubMed 1288127
  • Griffiths JR, Robinson SP. The OxyLite: a fibre-optic oxygen sensor. Br J Radiol. 1999 Jul;72(859):627-30. doi: 10.1259/bjr.72.859.10624317. No abstract available.

    PubMed 10624317
  • Scheffler A, Rieger H. Clinical information content of transcutaneous oxymetry (tcpO2) in peripheral arterial occlusive disease (a review of the methodological and clinical literature with a special reference to critical limb ischaemia). Vasa. 1992;21(2):111-26.

    PubMed 1621428
  • Barker SJ, Tremper KK. Pulse oximetry: applications and limitations. Int Anesthesiol Clin. 1987 Fall;25(3):155-75. doi: 10.1097/00004311-198702530-00010.

    PubMed 3323062
  • Shah SA, Bachrach N, Spear SJ, Letbetter DS, Stone RA, Dhir R, Prichard JW, Brown HG, LaFramboise WA. Cutaneous wound analysis using hyperspectral imaging. Biotechniques. 2003 Feb;34(2):408-13. doi: 10.2144/03342pf01.

    PubMed 12613264
  • Zweier JL, Thompson-Gorman S, Kuppusamy P. Measurement of oxygen concentrations in the intact beating heart using electron paramagnetic resonance spectroscopy: a technique for measuring oxygen concentrations in situ. J Bioenerg Biomembr. 1991 Dec;23(6):855-71. doi: 10.1007/BF00786005.

    PubMed 1663949
  • Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72. doi: 10.1073/pnas.87.24.9868.

    PubMed 2124706

Questions about this trial

What is this clinical trial studying?

An observational study of Quantitative Validation of Imaging System, run by Chandan K Sen at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 28 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Non-Contact Oxygenation Imagiing (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01573390, which also lists 32 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in